Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 76.3 Million shares, which have been reported (via 13F filing form) to have a value of $907 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Matrix Capital Management Company, LP
Waltham, MA |
May 14, 2024 Q1 2024 |
13,959,973
shares
|
$166 Million
2.04% of portfolio
|
Q2 2023
Added 51.74%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2024 Q1 2024 |
11,574,821
shares
|
$138 Million
2.94% of portfolio
|
Q1 2024
Added 0.13%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
4,645,758
shares
|
$55.2 Million
0.0% of portfolio
|
Q1 2024
Reduced 0.84%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
4,398,625
shares
|
$52.3 Million
0.0% of portfolio
|
Q1 2024
Reduced 17.79%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
3,852,429
shares
|
$45.8 Million
0.01% of portfolio
|
Q1 2024
Added 4.63%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
3,785,652
shares
|
$45 Million
0.0% of portfolio
|
Q1 2024
Reduced 14.29%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
3,489,709
shares
|
$41.5 Million
0.01% of portfolio
|
Q1 2024
Added 20.17%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
3,319,086
shares
|
$39.4 Million
0.03% of portfolio
|
Q1 2024
Added 41.73%
|
|
|
Capital International Investors
Los Angeles, CA |
May 14, 2024 Q1 2024 |
2,819,664
shares
|
$33.5 Million
0.01% of portfolio
|
Q4 2023
Reduced 9.85%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
2,099,583
shares
|
$24.9 Million
23.31% of portfolio
|
Q2 2023
Added 15.07%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
May 13, 2024 Q1 2024 |
2,099,583
shares
|
$24.9 Million
4.44% of portfolio
|
Q4 2023
New holding
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 14, 2024 Q1 2024 |
1,998,700
shares
|
$23.7 Million
0.07% of portfolio
|
Q1 2024
Reduced 7.49%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2024 Q1 2024 |
1,516,183
shares
|
$18 Million
3.91% of portfolio
|
Q1 2024
New holding
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
1,437,026
shares
|
$17.1 Million
0.22% of portfolio
|
Q1 2024
Added 2.38%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,302,237
shares
|
$15.5 Million
0.0% of portfolio
|
Q1 2024
Added 3.87%
|
|
|
Primecap Management CO
Pasadena, CA |
May 13, 2024 Q1 2024 |
1,164,610
shares
|
$13.8 Million
0.01% of portfolio
|
Q1 2024
Added 13.8%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
May 14, 2024 Q1 2024 |
1,155,236
shares
|
$13.7 Million
0.14% of portfolio
|
Q1 2024
Added 235.22%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,037,409
shares
|
$12.3 Million
0.0% of portfolio
|
Q1 2024
Added 70.21%
|
|
|
Tybourne Capital Management (Hk) LTD
Hong Kong, K3 |
May 15, 2024 Q1 2024 |
961,486
shares
|
$11.4 Million
3.39% of portfolio
|
Q2 2023
Reduced 41.1%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2024 Q1 2024 |
944,917
shares
|
$11.2 Million
0.56% of portfolio
|
Q1 2024
Added 136.23%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
723,656
shares
|
$8.6 Million
0.0% of portfolio
|
Q1 2024
Reduced 0.05%
|
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
523,702
shares
|
$6.22 Million
0.0% of portfolio
|
Q1 2024
Reduced 1.19%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
490,000
shares
|
$5.82 Million
2.72% of portfolio
|
Q2 2023
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
475,956
shares
|
$5.65 Million
0.0% of portfolio
|
Q1 2024
Reduced 33.77%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
455,937
shares
|
$5.42 Million
0.0% of portfolio
|
Q1 2024
Added 2.27%
|
|